The estimand framework a crucial step in defining the question of interest, needing interdisciplinary collaboration for valid inference. In this webinar, we will clarify the concept of estimands, the different types of intercurrent events and how to handle them, using examples. Emphasis will be placed on the importance...
Transitioning from preclinical to clinical development is a critical step in drug development, often accompanied by significant challenges. This webinar will explore key considerations from a clinical pharmacology perspective, and explore potential solutions to establish a robust plan for your First-In-Human study. Speaker: Tom Habraken...
Join the first webinar of our series on the WHY, HOW, WHO, WHAT and WHEN of Regulatory Writing on Thursday 16 January 2025. In this webinar, we will be covering the general aspects; giving you a brief introduction into regulatory affairs and the documentation required...
Join our second webinar of the series on the WHY, HOW, WHO, WHAT and WHEN of Regulatory Writing on Thursday 6 February 2025. Following our first webinar on general aspects on Thursday 16 January 2025, this webinar will delve deeper into the various documents required...
